These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 20576573)

  • 1. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
    Wang Z; Vince R
    Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
    J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Vince R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
    Kireev DB; Chrétien JR; Grierson DS; Monneret C
    J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase.
    Gupta P; Kumar R; Garg P; Singh IP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of novel lipid-functionalized PNA monomers as potential HIV-1 non-nucleoside reverse transcriptase and/or integrase inhibitors.
    Thomas MG; Maga G; Mouscadet JF; Howarth NM
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1063-6. PubMed ID: 18058537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
    Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
    Gleenberg IO; Herschhorn A; Hizi A
    J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mitchell ML; Son JC; Lee IY; Lee CK; Kim HS; Guo H; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Eisenberg G; Geleziunas R; Xu L; Kim CU
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1585-8. PubMed ID: 20137928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
    Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
    Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
    J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.
    Tang J; Maddali K; Dreis CD; Sham YY; Vince R; Pommier Y; Wang Z
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2400-2. PubMed ID: 21392991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.
    Barreca ML; Rao A; De Luca L; Zappalà M; Monforte AM; Maga G; Pannecouque C; Balzarini J; De Clercq E; Chimirri A; Monforte P
    J Med Chem; 2005 May; 48(9):3433-7. PubMed ID: 15857150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of HIV-1 reverse transcriptase and integrase activity by gold(III) complexes in direct biochemical assays.
    Mphahlele M; Papathanasopoulos M; Cinellu MA; Coyanis M; Mosebi S; Traut T; Modise R; Coates J; Hewer R
    Bioorg Med Chem; 2012 Jan; 20(1):401-7. PubMed ID: 22104436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.